Retention in Antiretroviral Programs in Sub-Saharan Africa

In a systematic review of such programs, only about 60% of patients were known to be alive and still taking antiretroviral therapy at 2 years.

Initial studies of antiretroviral treatment programs in sub-Saharan Africa have been quite promising, with virologic outcomes and adherence rates comparable to those seen in the U.S. (ACC Apr 12 2006 and ACC Sep 1 2006). Whether these programs will succeed in the long term depends partly on patient retention.

To examine retention rates, investigators reviewed 32 reports that detailed the proportion of adult patients retained for ≥6 months in non-research–oriented antiretroviral programs in sub-Saharan Africa. The programs described involved more than 74,000 patients in 13 countries, and most (52%) were implemented by the public sector. Fifteen programs (45%) provided free treatment, 6 (18%) provided treatment at low cost, and 6 required full…

Reviewing Author

Rebeca M. Plank, MD

Retention in Antiretroviral Programs in Sub-Saharan Africa

Topics

Reviewing Author